PAR 8.00% 23.0¢ paradigm biopharmaceuticals limited..

Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-3

  1. 572 Posts.
    lightbulb Created with Sketch. 55
    delayed by a year.... ouch. Funny how HC punters knew of the change in protocol about 3 months earlier than the market. top notch governance!!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.